查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1676763

皮膚填充劑和肉毒桿菌毒素市場按產品類型、材料、應用和最終用戶分類 - 2025 年至 2030 年全球預測

Dermal Fillers & Botulinum Toxin Market by Product Type, Material, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計皮膚填充劑和肉毒桿菌毒素市場規模將在 2024 年達到 142.9 億美元，2025 年達到 155 億美元，到 2030 年將達到 234.9 億美元，複合年成長率為 8.63%。

主要市場統計數據
基準年 2024 年 142.9億美元
預計 2025 年 155億美元
預測年份 2030 234.9億美元
複合年成長率（%） 8.63%

在充滿活力的美容和治療解決方案領域，真皮填充劑和肉毒桿菌毒素市場正在迅速發展。過去幾十年來，技術和治療方法取得了重大進步，改變了市場格局。本介紹為深入了解重新定義產業標準的複雜市場動態、細分策略和區域發展奠定了基礎。產品配方和遞送技術的不斷改進，加上對病人安全性和療效的日益關注，正在刺激現有企業和新參與企業的創新。隨著對微創和有效美容手術的需求不斷成長，各個領域的相關人員都被迫適應日益複雜化、監管越來越嚴格和消費者期望不斷變化等特徵的市場。本報告全面介紹了從變革性變化和關鍵細分見解到區域亮點和可操作的建議，旨在為市場現狀和未來發展提供清晰、明智的觀點。

皮膚填充劑和肉毒桿菌毒素市場的轉型

近年來，皮膚填充劑和肉毒桿菌毒素的市場模式發生了顯著變化。生物技術和製劑科學的進步不僅提高了治療效果，而且擴大了其在美容和治療性介入的應用範圍。從歷史上看，傳統方法一直佔據市場主導地位，但隨著研究和開發的活性化，新型配方不斷湧現，可以提供更可預測的結果並降低副作用的風險。這種演變是顯而易見的，因為現在的產品可以根據消費者的不同需求進行客製化，從細微的增強到更全面的臉部回春手術。消費者偏好的改變、對非手術程序的認知的不斷提高以及技術的進步正在改變市場動態。行業領導者正在大力投資數位參與和個人化行銷策略，以接觸更多的消費者，同時監管機構不斷更新標準以確保患者安全。技術創新、消費者需求和監管之間的動態交互作用凸顯了當今市場的競爭激烈程度，並為未來的成長和投資奠定了堅實的基礎。

影響市場策略的關鍵細分洞察

深入的市場研究將揭示有價值的細分見解，有助於推動您的目標策略。依產品類型，分為肉毒桿菌素製劑及皮膚填充劑，前者又分為肉毒桿菌素A至G製劑等多種類型。另一方面，根據皮膚填充劑的化學成分，皮膚填充劑又分為羥基磷灰石鈣填充劑、透明質酸填充劑、PMMA（聚甲基丙烯酸甲酯）填充劑和聚乳酸填充劑。這些分類使得公司能夠根據特定消費者的需求對其產品進行細分。基於材料的細分進一步將市場格局區分為生物分解性和非生物分解的填料，這一重要區別符合消費者對永續性和長期安全性不斷變化的偏好。此外，按應用進行細分可發現兩個主要途徑。這些包括涉及臉頰增大、臉部輪廓矯正、唇部增強、疤痕治療和減少皺紋等程序的美容應用，以及針對眼瞼痙攣、頸部肌肌張力不全症、慢性偏頭痛和膀胱過動症症等病症的治療應用。除了產品動態之外，最終用戶的細分涵蓋各種醫療保健環境，例如皮膚科診所、醫院和專門的醫療水療中心。這種多層次的方法提供了對市場的多方面視角，使相關人員能夠根據產品創新和消費行為制定有針對性的策略。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 可支配收入的增加推動了個人和美容治療支出的增加
      • 全球對微創和非手術美容手術的需求日益增加
      • 越來越多的老年人口將抗老療程視為首選
    • 限制因素
      • 嚴格的法規結構減緩了新產品的推出
    • 機會
      • 開發更持久、更自然的真皮填充劑產品滿足了消費者的需求
      • 線上諮詢和電子商務平台的普及提高了注射劑的獲取機會。
    • 任務
      • 與皮膚填充劑和肉毒桿菌毒素相關的併發症和副作用的風險
  • 市場區隔分析
    • 產品類型：肉毒桿菌毒素因其減少皺紋的能力而使用增加
    • 最終用戶：皮膚科診所憑藉其專業知識和對皮膚健康的關注，對皮膚填充劑和肉毒桿菌毒素的使用正在增加。
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章皮膚填充劑和肉毒桿菌毒素市場（依產品種類）

  • 肉毒桿菌毒素的種類
    • 肉毒桿菌毒素 A
    • 肉毒桿菌 B
    • 肉毒桿菌C
    • 肉毒毒素D
    • 肉毒桿菌 E
    • 肉毒桿菌毒素 F
    • 肉毒桿菌毒素G
  • 皮膚填充劑
    • 烴基磷灰石鈣填充劑
    • 透明質酸填充劑
    • PMMA（聚甲基丙烯酸甲酯）填料
    • 聚乳酸填料

第 7 章皮膚填充劑和肉毒桿菌毒素市場（按材料）

  • 生物分解性填料
  • 非生物分解的填充劑

第 8 章皮膚填充劑和肉毒桿菌毒素市場（按應用）

  • 美學
    • 豐頰術
    • 臉部線條矯正
    • 豐唇
    • 疤痕治療
    • 減少皺紋
  • 治療
    • 眼瞼痙攣
    • 頸部肌張力不全症
    • 慢性偏頭痛
    • 膀胱過動症

第 9 章皮膚填充劑和肉毒桿菌毒素市場（按最終用戶）

  • 皮膚科診所
  • 醫院
  • 醫療水療

10. 美國皮膚填充劑和肉毒桿菌毒素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

11. 亞太地區皮膚填充劑和肉毒桿菌毒素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

12. 歐洲、中東和非洲皮膚填充劑和肉毒桿菌毒素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章 競爭格局

  • 2024 年市場佔有率分析
  • FPNV 定位矩陣，2024 年
  • 競爭情境分析
  • 戰略分析與建議

公司列表

  • AbbVie Inc.
  • Anika Therapeutics, Inc.
  • BMI KOREA CO., LTD.
  • BNC Global
  • CROMA-PHARMA GmbH
  • Crown Laboratories, Inc.
  • Daewoong Pharmaceutical Co., Ltd.
  • Evolus, Inc.
  • Galderma SA
  • Gufic Biosciences
  • Hugel, Inc.
  • Ipsen SA
  • LG Chem, Ltd.
  • Medytox, Inc.
  • Merz Pharmaceuticals GmbH
  • Prollenium Medical Technologies.
  • Reborn Aesthetic Clinic Pty Ltd
  • Sinclair Pharma Ltd.
  • TEOXANE SA
  • Tiger Aesthetics Medical, LLC
Product Code: MRR-867BED9A9E66

The Dermal Fillers & Botulinum Toxin Market was valued at USD 14.29 billion in 2024 and is projected to grow to USD 15.50 billion in 2025, with a CAGR of 8.63%, reaching USD 23.49 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 14.29 billion
Estimated Year [2025] USD 15.50 billion
Forecast Year [2030] USD 23.49 billion
CAGR (%) 8.63%

In the dynamic world of aesthetic and therapeutic solutions, the dermal fillers and botulinum toxin market has experienced rapid evolution. The past couple of decades have seen significant advancements in technologies and treatment methodologies, leading to a transformative market landscape. This introduction sets the stage for a detailed exploration of the intricate market trends, segmentation strategies, and regional developments that have redefined industry standards. The continuous improvement in product formulations and delivery techniques, combined with an increasing focus on patient safety and efficacy, has propelled both established players and new entrants to innovate. As the demand for minimally invasive and effective aesthetic procedures grows, stakeholders across the spectrum are compelled to adapt to a market marked by sophistication, rigorous regulation, and evolving consumer expectations. This article unfolds a comprehensive narrative-from transformative shifts and key segmentation insights to regional highlights and actionable recommendations-designed to offer a clear, informed perspective on the market's current status and future trajectory.

Transformative Shifts in the Global Market Landscape

Recent years have brought about transformative shifts that have significantly altered the dermal fillers and botulinum toxin market landscape. Advances in biotechnology and formulation science have not only refined the efficacy of treatments but also expanded the range of applications in both aesthetics and therapeutic interventions. Historically, traditional approaches dominated the market; however, increased research and development have fostered the emergence of novel formulations that offer more predictable outcomes and reduced risk of side effects. This evolution is evident in the way products are now tailored to meet the diverse needs of consumers, ranging from subtle enhancements to more comprehensive facial rejuvenation procedures. Alongside technological advancements, changing consumer preferences and increased awareness about non-surgical procedures have driven a shift in market dynamics. Industry leaders are investing heavily in digital engagement and personalized marketing strategies to capture a broader audience, while regulatory authorities continue to update standards that ensure patient safety. Such dynamic interplay between innovation, consumer demand, and regulation underscores the competitive intensity in the market today, setting a robust stage for future growth and investment.

Key Segmentation Insights Shaping Market Strategies

A detailed examination of the market reveals valuable segmentation insights that are instrumental in driving targeted strategies. The product type segmentation distinguishes between botulinum toxin formulations and dermal fillers, with the former further categorized into diverse types which include formulations ranging from Botulinum Toxin A through G. On the other hand, dermal fillers are redistributed based on chemical composition into Calcium Hydroxylapatite Fillers, Hyaluronic Acid Fillers, PMMA (Polymethyl-Methacrylate) Fillers, and Polylactic Acid Fillers. These classifications provide companies with the nuanced ability to segment product offerings based on specific consumer needs. Material-based segmentation further differentiates the market landscape into biodegradable fillers and non-biodegradable fillers, an important distinction that aligns with evolving consumer preferences for sustainability and long-term safety. Additionally, application-based segmentation unveils two primary avenues: aesthetic applications, which involve procedures such as cheek augmentation, facial line correction, lip enhancement, scar treatment, and wrinkle reduction; and therapeutic applications, which address conditions like blepharospasm, cervical dystonia, chronic migraine, and overactive bladder. Beyond the product dynamics, segmentation by end user spans across various healthcare settings, including dermatology clinics, hospitals, and dedicated medical spas. This layered approach provides a multifaceted view of the market, enabling stakeholders to craft precise strategies based on both product innovation and consumer behavior.

Based on Product Type, market is studied across Botulinum Toxin Type and Dermal Fillers. The Botulinum Toxin Type is further studied across Botulinum Toxin A, Botulinum Toxin B, Botulinum Toxin C, Botulinum Toxin D, Botulinum Toxin E, Botulinum Toxin F, and Botulinum Toxin G. The Dermal Fillers is further studied across Calcium Hydroxylapatite Fillers, Hyaluronic Acid Fillers, PMMA (Polymethyl-Methacrylate) Fillers, and Polylactic Acid Fillers.

Based on Material, market is studied across Biodegradable Fillers and Non-Biodegradable Fillers.

Based on Application, market is studied across Aesthetics and Therapeutic. The Aesthetics is further studied across Cheek Augmentation, Facial Line Correction, Lip Enhancement, Scar Treatment, and Wrinkle Reduction. The Therapeutic is further studied across Blepharospasm, Cervical Dystonia, Chronic Migraine, and Overactive Bladder.

Based on End User, market is studied across Dermatology Clinics, Hospitals, and Medical Spas.

Global Regional Insights Informing Market Direction

Regional variations underscore significant differences in market maturity and consumer adoption, thereby shaping the overall strategy for product positioning and growth. In the Americas, robust economic frameworks and high healthcare spending combine with a proactive regulatory environment to foster rapid product adoption and innovation. The landscape in Europe, Middle East, and Africa reveals a blend of mature markets alongside emerging growth opportunities where new trends in aesthetic medicine are taking hold, driven by increased awareness and a growing demand for minimally invasive procedures. Meanwhile, the Asia-Pacific region presents a compelling growth story as rising disposable incomes, expanding healthcare infrastructures, and a cultural shift towards embracing non-surgical aesthetics fuel demand. These regional insights highlight the importance of localized market strategies while reinforcing the need for global innovation, as companies pivot to meet diverse consumer expectations and regulatory requirements across different geographies. Each region offers unique opportunities as well as challenges that require organizations to adopt flexible, yet robust, approaches to remain competitive in this multifaceted market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Driving Market Innovation

The competitive landscape is bolstered by a number of key companies that continue to play pivotal roles in shaping the direction of the market. Notable industry leaders include AbbVie Inc., Anika Therapeutics, Inc., BMI KOREA CO., LTD., and BNC Global, each bringing distinct strengths in research, development, and market penetration. CROMA-PHARMA GmbH, Crown Laboratories, Inc., and Daewoong Pharmaceutical Co., Ltd. have further fortified the industry with their innovative approaches, while Evolus, Inc. and Galderma S.A. drive quality improvements through continuous product enhancements and customer-centric solutions. The market's competitive edge is further sharpened by players such as Gufic Biosciences, Hugel, Inc., Ipsen S.A., and LG Chem, Ltd., who are known for their commitment to excellence in both product efficacy and safety. Companies like Medytox, Inc., Merz Pharmaceuticals GmbH, Prollenium Medical Technologies, Reborn Aesthetic Clinic Pty Ltd, Sinclair Pharma Ltd., TEOXANE SA, and Tiger Aesthetics Medical, LLC also contribute significantly to the innovation landscape, ensuring a steady infusion of breakthrough treatments and advanced technologies. Collectively, these companies not only enhance the market's competitiveness but also drive the overall evolution of aesthetic and therapeutic treatment modalities.

The report delves into recent significant developments in the Dermal Fillers & Botulinum Toxin Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Anika Therapeutics, Inc., BMI KOREA CO., LTD., BNC Global, CROMA-PHARMA GmbH, Crown Laboratories, Inc., Daewoong Pharmaceutical Co., Ltd., Evolus, Inc., Galderma S.A., Gufic Biosciences, Hugel, Inc., Ipsen S.A., LG Chem, Ltd., Medytox, Inc., Merz Pharmaceuticals GmbH, Prollenium Medical Technologies., Reborn Aesthetic Clinic Pty Ltd, Sinclair Pharma Ltd., TEOXANE SA, and Tiger Aesthetics Medical, LLC. Strategic Recommendations to Capitalize on Market Opportunities

Industry leaders are encouraged to adopt proactive strategies to harness the prevailing market opportunities. It is imperative to invest in advanced research and development to pioneer next-generation formulations that address both aesthetic and therapeutic needs. Emphasis should be placed on ensuring product safety and efficacy, a factor that has become central to consumer decision-making in this market. Companies should consider expanding their product portfolios to encompass the entire spectrum of injectable treatments, thereby appealing to a broader range of demographics. Furthermore, establishing strategic partnerships and collaborations can facilitate faster technology adoption and improve market penetration, especially in emerging regions. Leaders should also focus on digital transformation by leveraging data analytics to tailor marketing strategies that resonate with specific consumer segments. On the operational front, optimizing supply chain logistics and quality control measures will be pivotal in maintaining a competitive edge. Engaging in active dialogue with regulatory authorities and participating in industry forums can also provide early insights into evolving standards and best practices. Through these actions, companies can not only secure immediate market gains but also lay a sustainable foundation for long-term growth.

Concluding Observations on Market Evolution

In summary, the dermal fillers and botulinum toxin market is undergoing a period of robust transformation fueled by innovations in product development, evolving consumer expectations, and shifting regulatory landscapes. The comprehensive segmentation insights illustrate how varied product offerings, application areas, and end-user requirements collectively contribute to a dynamic, multilingual market environment. Regional disparities further highlight that while some markets are mature and competitive, others offer substantial growth potential driven by increasing demand and infrastructural investments. Overall, industry leaders who are able to navigate these complexities with informed strategies and agile operational practices are well positioned to capitalize on emerging opportunities. The integration of cutting-edge technology with strategic market insights will undoubtedly continue to propel the market forward, ensuring that patient outcomes and product performance remain at the forefront of innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing disposable income contributing to higher expenditure on personal and aesthetic treatments
      • 5.1.1.2. Growing demand for minimally invasive and non-surgical aesthetic procedures worldwide
      • 5.1.1.3. Increasing prevalence of aging population seeing anti-aging treatments as preferred options
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory frameworks delay the approval and introduction of new products
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of longer-lasting and more natural-looking dermal filler products meets consumer demands
      • 5.1.3.2. Increased availability of online consultations and e-commerce platforms enhancing accessibility to injectables
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of complications and side effects associated with dermal fillers & botulinum toxin
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising utilization of botulinum toxin due to its efficacy in reducing the appearance of wrinkles
    • 5.2.2. End User: Growing usage of dermal fillers & botulinum toxin in dermatology clinics due to their specialized expertise and focus on skin health
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dermal Fillers & Botulinum Toxin Market, by Product Type

  • 6.1. Introduction
  • 6.2. Botulinum Toxin Type
    • 6.2.1. Botulinum Toxin A
    • 6.2.2. Botulinum Toxin B
    • 6.2.3. Botulinum Toxin C
    • 6.2.4. Botulinum Toxin D
    • 6.2.5. Botulinum Toxin E
    • 6.2.6. Botulinum Toxin F
    • 6.2.7. Botulinum Toxin G
  • 6.3. Dermal Fillers
    • 6.3.1. Calcium Hydroxylapatite Fillers
    • 6.3.2. Hyaluronic Acid Fillers
    • 6.3.3. PMMA (Polymethyl-Methacrylate) Fillers
    • 6.3.4. Polylactic Acid Fillers

7. Dermal Fillers & Botulinum Toxin Market, by Material

  • 7.1. Introduction
  • 7.2. Biodegradable Fillers
  • 7.3. Non-Biodegradable Fillers

8. Dermal Fillers & Botulinum Toxin Market, by Application

  • 8.1. Introduction
  • 8.2. Aesthetics
    • 8.2.1. Cheek Augmentation
    • 8.2.2. Facial Line Correction
    • 8.2.3. Lip Enhancement
    • 8.2.4. Scar Treatment
    • 8.2.5. Wrinkle Reduction
  • 8.3. Therapeutic
    • 8.3.1. Blepharospasm
    • 8.3.2. Cervical Dystonia
    • 8.3.3. Chronic Migraine
    • 8.3.4. Overactive Bladder

9. Dermal Fillers & Botulinum Toxin Market, by End User

  • 9.1. Introduction
  • 9.2. Dermatology Clinics
  • 9.3. Hospitals
  • 9.4. Medical Spas

10. Americas Dermal Fillers & Botulinum Toxin Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Dermal Fillers & Botulinum Toxin Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Dermal Fillers & Botulinum Toxin Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Allergan Aesthetics pioneers Botox approval for masseter muscle prominence treatment in China, eyeing global expansion
    • 13.3.2. Crown Laboratories strengthens competitive position in aesthetic and therapeutic markets through USD 924 million purchase of Revance Therapeutics
    • 13.3.3. Merz Aesthetics sets industry benchmark with groundbreaking FDA approval for XEOMIN treating upper facial lines
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Anika Therapeutics, Inc.
  • 3. BMI KOREA CO., LTD.
  • 4. BNC Global
  • 5. CROMA-PHARMA GmbH
  • 6. Crown Laboratories, Inc.
  • 7. Daewoong Pharmaceutical Co., Ltd.
  • 8. Evolus, Inc.
  • 9. Galderma S.A.
  • 10. Gufic Biosciences
  • 11. Hugel, Inc.
  • 12. Ipsen S.A.
  • 13. LG Chem, Ltd.
  • 14. Medytox, Inc.
  • 15. Merz Pharmaceuticals GmbH
  • 16. Prollenium Medical Technologies.
  • 17. Reborn Aesthetic Clinic Pty Ltd
  • 18. Sinclair Pharma Ltd.
  • 19. TEOXANE SA
  • 20. Tiger Aesthetics Medical, LLC

LIST OF FIGURES

  • FIGURE 1. DERMAL FILLERS & BOTULINUM TOXIN MARKET MULTI-CURRENCY
  • FIGURE 2. DERMAL FILLERS & BOTULINUM TOXIN MARKET MULTI-LANGUAGE
  • FIGURE 3. DERMAL FILLERS & BOTULINUM TOXIN MARKET RESEARCH PROCESS
  • FIGURE 4. DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. DERMAL FILLERS & BOTULINUM TOXIN MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. DERMAL FILLERS & BOTULINUM TOXIN MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DERMAL FILLERS & BOTULINUM TOXIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DERMAL FILLERS & BOTULINUM TOXIN MARKET DYNAMICS
  • TABLE 7. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN C, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN D, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN E, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN F, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN G, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY CALCIUM HYDROXYLAPATITE FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY HYALURONIC ACID FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PMMA (POLYMETHYL-METHACRYLATE) FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY POLYLACTIC ACID FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BIODEGRADABLE FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY NON-BIODEGRADABLE FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY CHEEK AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY FACIAL LINE CORRECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY LIP ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY SCAR TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY WRINKLE REDUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BLEPHAROSPASM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY CERVICAL DYSTONIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY CHRONIC MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 295. POLAND DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY AESTHETICS, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 303. QATAR DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA DERMAL FILLERS & BOTULINUM TOXIN MARKET SIZE, BY BOTULINUM TOXIN TYPE, 2018-2030 (USD MILLION)

TABLE 306.